{"id":"https://openalex.org/W4361945200","doi":"https://doi.org/10.1158/1078-0432.c.6523340","title":"Data from Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer","display_name":"Data from Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361945200","doi":"https://doi.org/10.1158/1078-0432.c.6523340"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6523340","doi":"https://doi.org/10.1158/1078-0432.c.6523340","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6523340","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.c.6523340","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052487618","display_name":"Melinda L. Telli","orcid":"https://orcid.org/0000-0001-7993-1235","observed_orcids":["https://orcid.org/0000-0001-7993-1235"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melinda L. Telli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041593789","display_name":"Kirsten M. Timms","orcid":"https://orcid.org/0000-0003-4923-2518","observed_orcids":["https://orcid.org/0000-0003-4923-2518"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kirsten M. Timms","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114010273","display_name":"Julia Reid","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julia Reid","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004102701","display_name":"Bryan T. Hennessy","orcid":"https://orcid.org/0000-0002-7871-6477","observed_orcids":["https://orcid.org/0000-0002-7871-6477"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bryan Hennessy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005221518","display_name":"Gordon Brent Mills","orcid":"https://orcid.org/0000-0002-0144-9614","observed_orcids":["https://orcid.org/0000-0002-0144-9614"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gordon B. Mills","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029202324","display_name":"Kristin C. Jensen","orcid":"https://orcid.org/0000-0003-1177-9104","observed_orcids":["https://orcid.org/0000-0003-1177-9104"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kristin C. Jensen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021830443","display_name":"Zolt\u00e1n Sz\u00e1ll\u00e1si","orcid":"https://orcid.org/0000-0001-5395-7509","observed_orcids":["https://orcid.org/0000-0001-5395-7509"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zoltan Szallasi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112035683","display_name":"William Thomas Barry","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William T. Barry","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070245248","display_name":"Eric P. Winer","orcid":"https://orcid.org/0000-0002-8819-1723","observed_orcids":["https://orcid.org/0000-0002-8819-1723"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric P. Winer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051532432","display_name":"Nadine Tung","orcid":"https://orcid.org/0000-0003-1422-3734","observed_orcids":["https://orcid.org/0000-0003-1422-3734"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nadine M. Tung","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057580348","display_name":"Steven Jay Isakoff","orcid":"https://orcid.org/0000-0002-6677-1014","observed_orcids":["https://orcid.org/0000-0002-6677-1014"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven J. Isakoff","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013104624","display_name":"Paula D. Ryan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paula D. Ryan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090500227","display_name":"April Greene-Colozzi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"April Greene-Colozzi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006074290","display_name":"Alexander Gutin","orcid":"https://orcid.org/0000-0002-6565-3729","observed_orcids":["https://orcid.org/0000-0002-6565-3729"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander Gutin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072422593","display_name":"Zaina Sangale","orcid":"https://orcid.org/0000-0001-7382-1510","observed_orcids":["https://orcid.org/0000-0001-7382-1510"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zaina Sangale","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040919885","display_name":"Diana Iliev","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diana Iliev","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078405095","display_name":"Chris D. Neff","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chris Neff","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071147112","display_name":"Victor Abkevich","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Victor Abkevich","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077241291","display_name":"Joshua Timothy Jones","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joshua T. Jones","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071470387","display_name":"Jerry S. S. Lanchbury","orcid":"https://orcid.org/0000-0001-6747-4137","observed_orcids":["https://orcid.org/0000-0001-6747-4137"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jerry S. Lanchbury","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073892003","display_name":"Anne\u2010Renee Hartman","orcid":"https://orcid.org/0000-0003-3506-6440","observed_orcids":["https://orcid.org/0000-0003-3506-6440"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne-Renee Hartman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005206482","display_name":"Judy Ellen Garber","orcid":"https://orcid.org/0000-0001-9449-3982","observed_orcids":["https://orcid.org/0000-0001-9449-3982"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Judy E. Garber","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000788791","display_name":"James M. Ford","orcid":"https://orcid.org/0000-0002-2513-7025","observed_orcids":["https://orcid.org/0000-0002-2513-7025"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James M. Ford","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030179640","display_name":"Daniel P. Silver","orcid":"https://orcid.org/0000-0003-3771-806X","observed_orcids":["https://orcid.org/0000-0003-3771-806X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel P. Silver","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5015821699","display_name":"Andrea L. Richardson","orcid":"https://orcid.org/0000-0001-5221-1094","observed_orcids":["https://orcid.org/0000-0001-5221-1094"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrea L. Richardson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.5034000277519226,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.5034000277519226,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.4690000116825104,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.019099999219179153,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/homologous-recombination-deficiency","display_name":"homologous recombination deficiency","score":0.9399999976158142},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.972000002861023},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.9240000247955322},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.8410000205039978},{"id":"https://openalex.org/keywords/brca-mutations","display_name":"BRCA mutations","score":0.8410000205039978},{"id":"https://openalex.org/keywords/loss-of-heterozygosity","display_name":"loss of heterozygosity","score":0.9679999947547913},{"id":"https://openalex.org/keywords/telomeric-allelic-imbalance","display_name":"telomeric allelic imbalance","score":0.9959999918937683},{"id":"https://openalex.org/keywords/large-scale-state-transitions","display_name":"large-scale state transitions","score":0.9869999885559082},{"id":"https://openalex.org/keywords/genomic-instability","display_name":"genomic instability","score":0.878000020980835},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6809999942779541},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.8560000061988831},{"id":"https://openalex.org/keywords/residual-cancer-burden","display_name":"residual cancer burden","score":0.9139999747276306},{"id":"https://openalex.org/keywords/iniparib","display_name":"iniparib","score":0.8489999771118164},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.8410000205039978},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9919999837875366}],"concepts":[{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6560977101325989},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.6047684550285339},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6014911532402039},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5209992527961731},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.4729468822479248},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.46931716799736023},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.46851420402526855},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4522958993911743},{"id":"https://openalex.org/C143589142","wikidata":"https://www.wikidata.org/wiki/Q2617554","display_name":"Loss of heterozygosity","level":4,"score":0.4514278173446655},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.44894173741340637},{"id":"https://openalex.org/C178169997","wikidata":"https://www.wikidata.org/wiki/Q2892636","display_name":"Genome instability","level":4,"score":0.4408705234527588},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3607916235923767},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.3157135248184204},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.2314864695072174},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.15318313241004944},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.12551835179328918},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.12431740760803223},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09859448671340942}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.c.6523340","doi":"https://doi.org/10.1158/1078-0432.c.6523340","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6523340","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.c.6523340.v1","doi":"https://doi.org/10.1158/1078-0432.c.6523340.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6523340.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6523340","doi":"https://doi.org/10.1158/1078-0432.c.6523340","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6523340","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2295085830","https://openalex.org/W1613365595","https://openalex.org/W2572146725","https://openalex.org/W2779333875","https://openalex.org/W2405521611","https://openalex.org/W4379285494","https://openalex.org/W1994154807","https://openalex.org/W1629359172","https://openalex.org/W4213066090","https://openalex.org/W2049030247"],"abstract_inverted_index":{"Abstract":[0],"Purpose:BRCA1/2-mutated":[1],"and":[2,13,41,63,103,118,168,233],"some":[3],"sporadic":[4],"triple-negative":[5],"breast":[6],"cancers":[7],"(TNBC)":[8],"have":[9],"DNA":[10],"repair":[11],"defects":[12],"are":[14],"sensitive":[15],"to":[16,92,206,262,264],"DNA-damaging":[17],"therapeutics.":[18],"Recently,":[19],"three":[20,67],"independent":[21],"DNA-based":[22],"measures":[23],"of":[24,32,34,60,71,79,99,112,141,159,186],"genomic":[25],"instability":[26],"were":[27,196],"developed":[28],"on":[29],"the":[30,77,229,246],"basis":[31],"loss":[33],"heterozygosity":[35],"(LOH),":[36],"telomeric":[37],"allelic":[38],"imbalance":[39],"(TAI),":[40],"large-scale":[42],"state":[43],"transitions":[44],"(LST).":[45],"Experimental":[46],"Design:":[47],"We":[48,74],"assessed":[49],"a":[50,97,138,183],"combined":[51],"homologous":[52],"recombination":[53],"deficiency":[54,106,136,164,190,252],"(HRD)":[55],"score,":[56],"an":[57],"unweighted":[58],"sum":[59],"LOH,":[61],"TAI,":[62],"LST":[64],"scores,":[65],"in":[66,213,228,245],"neoadjuvant":[68,100,160,230,247],"TNBC":[69,254],"trials":[70,158],"platinum-containing":[72,265],"therapy.":[73,94,266],"then":[75],"tested":[76],"association":[78],"HR":[80,105,135,163,189,251],"deficiency,":[81],"defined":[82],"as":[83],"HRD":[84,217],"score":[85,111],"\u226542":[86],"or":[87,114],"BRCA1/2":[88,207,257],"mutation,":[89],"with":[90,215],"response":[91,121,210],"platinum-based":[93],"Results:":[95],"In":[96,155,182],"trial":[98],"platinum,":[101,231],"gemcitabine,":[102,232],"iniparib,":[104],"predicted":[107,165],"residual":[108],"cancer":[109],"burden":[110],"0":[113],"I":[115],"(RCB":[116],"0/I)":[117],"pathologic":[119],"complete":[120],"(pCR;":[122],"OR":[123,129,176],"=":[124,127,130,133,150,153,171,174,177,180,199,202,222,226,239,243],"4.96,":[125],"P":[126,132,152,173,179,201,221,225,238,242],"0.0036;":[128],"6.52,":[131],"0.0058).":[134],"remained":[137],"significant":[139],"predictor":[140],"RCB":[142,166,187,219,236],"0/I":[143,167,220,237],"when":[144,193],"adjusted":[145],"for":[146],"clinical":[147,194],"variables":[148,195],"(OR":[149,170,198],"5.86,":[151],"0.012).":[154],"two":[156],"other":[157],"cisplatin":[161,248],"therapy,":[162],"pCR":[169,224,241],"10.18,":[172],"0.0011;":[175],"17.00,":[178],"0.0066).":[181],"multivariable":[184],"model":[185],"0/I,":[188],"retained":[191],"significance":[192],"included":[197],"12.08,":[200],"0.0017).":[203],"When":[204],"restricted":[205],"nonmutated":[208,258],"tumors,":[209,255],"was":[211],"higher":[212],"patients":[214],"high":[216],"scores:":[218],"0.062,":[223],"0.063":[227],"iniparib":[234],"trial;":[235],"0.0039,":[240],"0.018":[244],"trials.":[249],"Conclusions:":[250],"identifies":[253],"including":[256],"tumors":[259],"more":[260],"likely":[261],"respond":[263],"Clin":[267],"Cancer":[268],"Res;":[269],"22(15);":[270],"3764\u201373.":[271],"\u00a92016":[272],"AACR.":[273]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}